Cecile Donadille
Marseille, 13385, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Home Cultivation of Cannabis in a Context of Prohibition: Results from Two Online Cross-Sectional Surveys of People Using Cannabis Daily in France.
Journal: International journal of environmental research and public health
Published: May 12, 2025
Differences between men who have sex with men that use drugs and engage in chemsex and those who do not engage in chemsex in the French ANRS-PREVENIR cohort: the need to rethink harm reduction services.
Journal: Substance abuse treatment, prevention, and policy
Published: October 31, 2024
Willingness to use a drug checking service for cannabis and cannabis-based products: results from an online survey of people who regularly use cannabis in France.
Journal: Harm reduction journal
Published: July 25, 2024
Prevalence of stimulant use and the role of opioid agonist treatment among people who inject drugs in France: Results from the COSINUS cohort study.
Journal: Drug and alcohol review
Published: December 13, 2023
Cost-effectiveness of drug consumption rooms in France: a modelling study.
Journal: BMC public health
Published: September 28, 2023
Correction: Non‑disclosure of drug injection practices as a barrier to HCV testing: results from the PrebupIV community‑based research study.
Journal: Harm reduction journal
Published: August 05, 2023
Exclusive Therapeutic Use of Cannabis in a Large Sample of Daily Cannabis Users in France: A Cross-Sectional Survey.
Journal: Journal of psychoactive drugs
Published: June 14, 2023
Drug consumption rooms are effective to reduce at-risk practices associated with HIV/HCV infections among people who inject drugs: Results from the COSINUS cohort study.
Journal: Addiction (Abingdon, England)
Published: November 11, 2022
Perception of PrEP-related stigma in PrEP users: Results from the ANRS-PREVENIR cohort.
Journal: HIV medicine
Published: November 07, 2022
Same-day initiation of bictegravir/emtricitabine/tenofovir alafenamide: Week 48 results of the FAST study-IMEA 055.
Journal: The Journal of antimicrobial chemotherapy
Published: October 25, 2022
Non-disclosure of drug injection practices as a barrier to HCV testing: results from the PrebupIV community-based research study.
Journal: Harm reduction journal
Published: October 06, 2022
Last Updated: 09/26/2026